# Carotid Risk Prediction (CRISP) Consortium

> **NCT04448353** · — · UNKNOWN · sponsor: **Elucid Bioimaging Inc.** · enrollment: 800 (estimated)

## Conditions studied

- Carotid Atherosclerosis

## Interventions

- **DIAGNOSTIC_TEST:** vascuCAP

## Key facts

- **NCT ID:** NCT04448353
- **Lead sponsor:** Elucid Bioimaging Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2021-12-15
- **Final completion:** 2022-04-30
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2021-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04448353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04448353, "Carotid Risk Prediction (CRISP) Consortium". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04448353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*